NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 56 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 200 | 0.0% | 0.00% | -100.0% |
| Q4 2016 | $1,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |